In May 2025, the FDA named Prasad, an oncologist who previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and Research.
Vinay Prasad, the U.S. Food and Drug Administration’s chief medical … [1213 chars]
U.S. FDA’s chief medical and science officer Prasad departs agency
